Q3 2023 Holdings
Filed 2023-11-14 | 69 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Karuna Therapeutics Inc | COM | 48576A100 | $233.5M | 1,381,149 | 14.7% |
| Natera Inc(NTRA) | COM | 632307104 | $137.2M | 3,100,560 | 8.7% |
| AstraZeneca PLC(AZN) | SPONSORED ADR | 046353108 | $92.3M | 1,362,836 | 5.8% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $75.0M | 728,404 | 4.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $70.6M | 754,032 | 4.5% |
| RayzeBio Inc | COM | 75525N107 | $53.7M | 2,419,528 | 3.4% |
| Dexcom Inc(DXCM) | COM | 252131107 | $51.3M | 550,197 | 3.2% |
| Aerovate Therapeutics Inc | COM | 008064107 | $51.0M | 3,758,686 | 3.2% |
| Intuitive Surgical Inc(ISRG) | COM | 46120E602 | $50.6M | 173,277 | 3.2% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $47.5M | 3,467,156 | 3.0% |
| Elanco Animal Health Inc(ELAN) | COM | 28414H103 | $40.6M | 3,610,024 | 2.6% |
| IShares TR(IWM)Put | RUSSELL 2000 ETF | 464287655 | $39.8M | 225,000 | 2.5% |
| argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $38.4M | 78,186 | 2.4% |
| Immatics NV(IMTX) | SHS | N44445109 | $37.7M | 3,251,509 | 2.4% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $37.3M | 695,375 | 2.4% |
| Kenvue Inc(KVUE) | COM | 49177J102 | $36.2M | 1,802,084 | 2.3% |
| Idexx Laboratories Inc(IDXX) | COM | 45168D104 | $34.1M | 77,881 | 2.1% |
| ImmunoGen Inc(IMGNEUR) | COM | 45253H101 | $32.5M | 2,045,202 | 2.0% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $31.2M | 1,060,164 | 2.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $28.0M | 1,037,187 | 1.8% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $24.3M | 1,211,641 | 1.5% |
| Spdr S&P 500 ETF Trust(SPY)Put | TR UNIT | 78462F103 | $21.4M | 50,000 | 1.3% |
| Exelixis Inc(EXEL)Put | COM | 30161Q104 | $19.9M | 912,600 | 1.3% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $18.2M | 830,764 | 1.1% |
| Inozyme Pharma Inc | COM | 45790W108 | $18.0M | 4,280,308 | 1.1% |
| Invesco QQQ TR | UNIT SER 1 | 46090E953 | $17.9M | 50,000 | 1.1% |
| MoonLake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $16.7M | 292,805 | 1.1% |
| Shockwave Med Inc | COM | SHOCKWAVE | $16.2M | 81,373 | 1.0% |
| Agenus Inc(AGENEUR) | COM | 00847G705 | $15.1M | 13,364,748 | 1.0% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $15.1M | 537,464 | 0.9% |
| Cytokinetics Inc(CYTK)Put | COM | 23282W605 | $14.7M | 500,000 | 0.9% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $13.7M | 941,817 | 0.9% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $13.6M | 743,294 | 0.9% |
| Y-mAbs Therapeutics Inc(YMABUSD) | COM | 984241109 | $12.0M | 2,194,278 | 0.8% |
| Celldex Therapeutics Inc(CLDX) | COM | 15117B202 | $11.7M | 424,259 | 0.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $10.2M | 202,119 | 0.6% |
| Crispr Therapeutics AG(CRSP)Put | NAMEN AKT | H17182108 | $9.1M | 200,000 | 0.6% |
| Syndax Pharmaceuticals Inc(SNDX)Call | COM | 87164F105 | $8.7M | 600,000 | 0.5% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $8.6M | 503,844 | 0.5% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM | 56854Q200 | $7.9M | 985,606 | 0.5% |
| Geron Corp(GERN) | COM | 374163103 | $7.8M | 3,702,546 | 0.5% |
| Syndax Pharmaceuticals Inc(SNDX)Put | COM | 87164F105 | $6.5M | 450,000 | 0.4% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $6.2M | 51,100 | 0.4% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $6.1M | 685,133 | 0.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $5.6M | 80,368 | 0.4% |
| Celldex Therapeutics Inc(CLDX)Put | COM | 15117B202 | $5.5M | 200,000 | 0.3% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $5.4M | 139,885 | 0.3% |
| Replimune Group Inc(REPL)Put | COM | 76029N106 | $5.4M | 313,100 | 0.3% |
| Replimune Group Inc(REPL)Call | COM | 76029N106 | $4.3M | 250,000 | 0.3% |
| Nextcure Inc | COM | 65343E108 | $3.4M | 2,671,856 | 0.2% |